IR-2023-141, Aug. 4, 2023
WASHINGTON — The Department of the Treasury and the Internal Revenue Service today issued guidance for manufacturers, producers and importers of certain drugs regarding the tax imposed by section 5000D of the Internal Revenue Code. Section 5000D was enacted as part of the Inflation Reduction Act. Read More